CCT1
CCT1
Outcome
The outcome of the project includes both development of AI Diagnostic System for
Alzheimer Disease as well development of Medication System. A brief explanation of both
segments are listed below:
Objective:
The goal of this project was to develop an AI-powered healthcare platform that leverages
advanced machine learning algorithms and MRI imaging to facilitate the early detection of
neurodegenerative diseases, such as Alzheimer's and Parkinson's. By integrating real-time
patient monitoring, the platform aims to assist healthcare professionals in making more
accurate and timely diagnoses, ultimately improving patient outcomes.
Key Components:
5 2. Healthcare Platform:
- Developed using Django for the backend, which manages data processing, storage, and
API integrations.
- React was used for the web interface, providing an intuitive and user-friendly platform
for healthcare professionals.
- Flutter was utilized to create a mobile application, enabling real-time monitoring and
access to patient data.
3. Cloud Integration:
- Hosted on Azure, leveraging its scalable infrastructure and robust security features.
- Azure Databases for PostgreSQL was used to handle data storage, ensuring efficient and
reliable access to patient records and MRI data.
Outcome:
The project successfully created a functional prototype of the healthcare platform. Initial
testing indicated that the AI models could accurately detect early signs of
neurodegenerative diseases with a significant degree of accuracy. This tool has the potential
Directorate of University Advancement & Financial Assistance
NED University of Engineering and Technology
to greatly enhance the diagnostic process, leading to earlier intervention and better
management of neurodegenerative conditions.
Acknowledgements:
We would like to express our gratitude to Dr. Saman Hina and Dr. Muhammad Mubashir
Khan for their guidance and supervision. We also thank Microsoft for Startups for funding
this project, providing essential resources that contributed to the project's success.
Competitive Advantage or Unique Selling Proposition (Cost Reduction, Process improvement,
3. Process Improvement:
- How: The platform automates the analysis of MRI images, reducing the time and effort
required by radiologists and clinicians to interpret results. This automation speeds up the
diagnostic process, allowing healthcare professionals to focus on patient care rather than
data processing.
- Why: The healthcare industry is under constant pressure to improve efficiency and
reduce costs. By streamlining the diagnostic process, the platform offers significant time
savings and reduces the potential for human error, leading to better patient outcomes.
Directorate of University Advancement & Financial Assistance
NED University of Engineering and Technology
- When: With the increasing demand for healthcare services, particularly in the diagnosis
and management of chronic conditions, the need for process improvements in healthcare
has never been more critical.
- What: The platform's ability to improve diagnostic processes makes it a valuable asset for
healthcare providers looking to enhance efficiency, reduce costs, and deliver better patient
care.
Attainment of any SDG (e.g. How it is achieved and why it is necessary for the region)
How it is Achieved:
- *Early Detection and Prevention:* The AI-driven healthcare platform developed in this
project is designed to enhance the early detection of neurodegenerative diseases such as
Alzheimer's and Parkinson's. By utilizing advanced machine learning algorithms and MRI
imaging, the platform can identify early signs of these conditions, enabling timely
intervention and management. Early detection is crucial for slowing disease progression,
improving patient quality of life, and reducing the long-term burden on healthcare systems.
- Accessibility: The platform is designed to be scalable and can be integrated into healthcare
systems in both urban and rural areas. This ensures that even regions with limited access to
specialized healthcare services can benefit from advanced diagnostic tools, helping to bridge
a
the healthcare disparity gap.
Healthcare System Strain: Many regions face challenges related to overburdened healthcare
systems, with limited resources and a shortage of specialized healthcare professionals. The
AI-driven platform can alleviate some of this pressure by automating parts of the diagnostic
process, allowing healthcare providers to manage more patients effectively and efficiently.
- Alignment with Global Health Initiatives: Achieving SDG 3 is crucial for the region’s overall
development and well-being. By integrating advanced healthcare technologies like AI, the
region can make significant strides towards this goal, improving the health and well-being
of its population. This alignment not only fulfills a moral imperative but also positions the
region as a leader in adopting innovative healthcare solutions.
b Energy Efficiency:
- AI and Cloud Computing: The healthcare platform utilizes AI models and cloud computing
resources, which are hosted on Azure. Azure data centers are designed with energy
Carbon Reduction:
- Cloud-Based Operations: By hosting the platform on Azure, which is committed to
becoming carbon negative by 2030, the project contributes to carbon reduction efforts.
Azure's use of renewable energy sources for powering its data centers means that the
carbon footprint associated with the platform’s operations is significantly lower than it
would be if hosted on traditional, non-green infrastructure.
- Telemedicine and Remote Monitoring: The platform enables remote monitoring and
diagnosis, reducing the need for patients to travel frequently to healthcare facilities. This
reduction in travel not only saves time and resources but also contributes to lower carbon
emissions associated with transportation. By facilitating telemedicine, the platform
supports a more sustainable healthcare model that minimizes environmental impact.
- Paperless Operations: The digitization of patient records, MRI scans, and diagnostic
reports through the platform reduces the reliance on paper-based documentation. This shift
to electronic records not only streamlines healthcare operations but also contributes to
reducing deforestation and lowering the carbon emissions associated with paper
production and waste.
- Scalability and Flexibility: The cloud-based nature of the platform allows for
scalable deployment, meaning that healthcare facilities can adjust their usage based
on demand. This flexibility reduces the need for investing in high-capacity systems
that may be underutilized, leading to cost savings.
Expanding of Market share (e.g. how it expand and what is the problem with the current market
Target Market
Target Market for the AI-Driven Healthcare Platform
1. Healthcare Providers:
o Industries: Hospitals, diagnostic centers, and specialty clinics.
o Details: These institutions are primary end-users of the platform, as they
require advanced diagnostic tools to enhance their capabilities in detecting
and managing neurodegenerative diseases. The platform enables healthcare
providers to offer more accurate and timely diagnoses, improving patient
care and operational efficiency.
2. Radiologists and Clinicians:
7
o Groups: Medical professionals specializing in diagnostic imaging and
disease management.
o Details: Radiologists and clinicians use the platform for automated MRI
image analysis, which streamlines their workflow and reduces the time
spent on manual interpretation. The platform’s advanced AI algorithms
support these professionals in delivering more precise diagnoses and
treatment plans.
3. Patients:
o Groups: Individuals diagnosed with or at risk of neurodegenerative
diseases, as well as those seeking early detection and preventive care.
o Details: Patients benefit from the platform’s early detection capabilities and
remote monitoring features. By providing accurate and timely diagnostic
information, the platform supports better patient outcomes and allows for
earlier intervention, which can significantly enhance quality of life.
4. Healthcare Facilities in Underserved Areas:
o Groups: Clinics and healthcare centers in remote or underserved regions
with limited access to advanced diagnostic tools.
o Details: These facilities can deploy the platform to improve access to
sophisticated diagnostic services. The platform’s cloud-based nature and
cost-effective pricing make it a viable option for institutions with limited
resources, helping to bridge gaps in healthcare access.
5. Small to Medium-Sized Healthcare Providers:
o Groups: Smaller hospitals, clinics, and private practices.
o Details: Smaller healthcare providers can leverage the platform’s
affordability and scalability to offer advanced diagnostic services without the
need for substantial capital investment. The platform’s ease of integration
and user-friendly interface make it an attractive solution for these providers.
6. Academic and Research Institutions:
o Groups: Universities and research organizations focusing on medical
research and technology development.
o Details: These institutions can utilize the platform for research purposes,
including studying neurodegenerative diseases and developing new
diagnostic methods. The platform’s advanced capabilities offer valuable data
and insights for academic research.
7. Government Health Agencies and Non-Profits:
o Groups: Public health organizations and non-governmental organizations
(NGOs) working on health initiatives.
o Details: Government agencies and NGOs can implement the platform to
support public health campaigns, enhance diagnostic capabilities in public
health programs, and address health disparities in underserved populations.